Background Angiotensin converting enzyme 2 (ACE2) plays a crucial role in the infection
cycle of SARS-CoV-2 responsible for formation of COVID-19 pandemic. In the …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infects host cells through
angiotensin-converting enzyme 2 (ACE2). Concurrently, the product of ACE2 action …

Background and purpose: The aim of this study was to investigate the effect of chronic
treatment with antihypertensive and non‐antihypertensive doses of zofenopril on …

Background Renin–angiotensin–aldosterone system (RAAS) is hypothesized to be in the
center of COVID pathophysiology as the angiotensin converting enzyme 2 (ACE2) …

Exogenous BH4 (tetrahydrobiopterin) has been shown to improve endothelial function in
cardiovascular disease; however, in the presence of elevated superoxide levels and …

SARS-CoV-2 impairs the renin-angiotensin-aledosterone system via binding ACE2 enzyme.
ACE2 plays a key role in the biosynthesis of angiotensin (1-7), catalyzing the conversion of …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible
for the current coronavirus disease 2019 (COVID-19). The main organ affected in this …

The new coronavirus infection (COVID-19) is a serious threat to humanity. Although its
pathogenesis has not been fully studied, angiotensin-converting enzyme 2 (ACE 2) has …

Angiotensin-converting enzyme 2 (ACE2) is the entry receptor for severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), the cause of Coronavirus Disease-2019 (COVID …

To examine the role of sulfhydryl (-SH) group in improvement of endothelial dysfunction with
angiotensin-converting enzyme (ACE) inhibitors in experimental high dose of methionine …